GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,169,000 | +88.0% | 10,000 | 0.0% | 0.58% | +88.5% |
| Q4 2020 | $1,154,000 | +18.5% | 10,000 | 0.0% | 0.30% | +7.4% |
| Q3 2020 | $974,000 | -20.6% | 10,000 | 0.0% | 0.28% | -31.4% |
| Q2 2020 | $1,227,000 | +40.2% | 10,000 | 0.0% | 0.41% | +14.0% |
| Q1 2020 | $875,000 | -16.3% | 10,000 | 0.0% | 0.36% | +4.9% |
| Q4 2019 | $1,045,000 | – | 10,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |